國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Tumor microenvironmentthe main drive...

Serpa, Jacinta.

Tumor microenvironmentthe main driver of metabolic adaptation /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Tumor microenvironmentedited by Jacinta Serpa.
其他題名:	the main driver of metabolic adaptation /
其他作者:	Serpa, Jacinta.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	vii, 443 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	TumorsMetabolism.
電子資源:	https://doi.org/10.1007/978-3-030-34025-4
ISBN:	9783030340254$q(electronic bk.)

Tumor microenvironmentthe main driver of metabolic adaptation /
Tumor microenvironmentthe main driver of metabolic adaptation /[electronic resource] :edited by Jacinta Serpa. - Cham :Springer International Publishing :2020. - vii, 443 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.12190065-2598 ;. - Advances in experimental medicine and biology ;946..

This book will allow readers to discover the crucial role of tumor microenvironment (TME) in the selection of cancer cells that are more prone to carry on cancer initiation and progression. The metabolic remodeling, as the basis of life overall, allows the adaptive establishment of a tumor in a certain TME, which in turn presents a variety of selective pressures. Coupled with the late diagnosis, the poor therapy response are the main hurdles limiting oncological disease control and eventual cure. Thus the metabolic plasticity of cancer cells often underlies chemoresistance. This edited work presents an exhaustive description and comprehensive view of cancer metabolism as a weapon used by cancer cells to adapt to TME. TME and the organ microenvironment is analyzed as a whole, considering cancer cells, stromal cells and microbiota. This complex circuit is observed as the support for disease development and therapy evasion but also as a valuable kernel, presenting new players to be targeted in a more precise cancer therapy. The various threads of cancer biology related to TME and metabolic adaptation will be addressed including: 1) key players in the metabolic network; 2) the way adaptive metabolic features are sustained by TME; 3) TME and metabolic signaling, accounting for cancer cells survival; 4) metabolic fitness driven limitations in therapy response, and 5) the way TME and cancer metabolism can be helpful in the design of new drugs. In addition, the usefulness, technical strengths and weaknesses of analytical techniques useful in cancer metabolomics will be presented in an integrative way. Moreover, the use of innovative and traditional in vitro and in vivo cancer models, as powerful tools to address the influence of TME in cancer progression and metabolic reprogramming will be also presented. This work was written by experts and dedicated to researchers with interests in cancer biology, TME, cancer metabolism and therapy. It will interest the Advances in Experimental Medicine and Biology readership, including basic researchers, analytic researchers, bio-engineers and clinicians.

ISBN: 9783030340254$q(electronic bk.)

Standard No.: 10.1007/978-3-030-34025-4doiSubjects--Topical Terms:

792520
Tumors
--Metabolism.

LC Class. No.: RC268.5 / .T866 2020

Dewey Class. No.: 571.978

Tumor microenvironmentthe main driver of metabolic adaptation /
LDR:03181nmm a2200325 a 4500 001 572295
003 DE-He213
005 20200727111112.0
006 m d
007 cr nn 008maaau
008 200925s2020 sz s 0 eng d
020 $a 9783030340254$q(electronic bk.)
020 $a 9783030340247$q(paper)
024 7 $a 10.1007/978-3-030-34025-4 $2 doi
035 $a 978-3-030-34025-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.5 $b .T866 2020
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 571.978 $2 23
090 $a RC268.5 $b .T925 2020
245 0 0 $a Tumor microenvironment $h [electronic resource] : $b the main driver of metabolic adaptation / $c edited by Jacinta Serpa.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a vii, 443 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1219
520 $a This book will allow readers to discover the crucial role of tumor microenvironment (TME) in the selection of cancer cells that are more prone to carry on cancer initiation and progression. The metabolic remodeling, as the basis of life overall, allows the adaptive establishment of a tumor in a certain TME, which in turn presents a variety of selective pressures. Coupled with the late diagnosis, the poor therapy response are the main hurdles limiting oncological disease control and eventual cure. Thus the metabolic plasticity of cancer cells often underlies chemoresistance. This edited work presents an exhaustive description and comprehensive view of cancer metabolism as a weapon used by cancer cells to adapt to TME. TME and the organ microenvironment is analyzed as a whole, considering cancer cells, stromal cells and microbiota. This complex circuit is observed as the support for disease development and therapy evasion but also as a valuable kernel, presenting new players to be targeted in a more precise cancer therapy. The various threads of cancer biology related to TME and metabolic adaptation will be addressed including: 1) key players in the metabolic network; 2) the way adaptive metabolic features are sustained by TME; 3) TME and metabolic signaling, accounting for cancer cells survival; 4) metabolic fitness driven limitations in therapy response, and 5) the way TME and cancer metabolism can be helpful in the design of new drugs. In addition, the usefulness, technical strengths and weaknesses of analytical techniques useful in cancer metabolomics will be presented in an integrative way. Moreover, the use of innovative and traditional in vitro and in vivo cancer models, as powerful tools to address the influence of TME in cancer progression and metabolic reprogramming will be also presented. This work was written by experts and dedicated to researchers with interests in cancer biology, TME, cancer metabolism and therapy. It will interest the Advances in Experimental Medicine and Biology readership, including basic researchers, analytic researchers, bio-engineers and clinicians.
650 0 $a Tumors $x Metabolism. $3 792520
650 0 $a Cancer cells $x Growth. $3 348071
650 0 $a Cancer cells $x Adaptation. $3 859282
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Human Genetics. $3 273658
650 2 4 $a Immunology. $3 189152
650 2 4 $a Human Physiology. $3 274509
650 2 4 $a Cell Biology. $3 274165
700 1 $a Serpa, Jacinta. $3 859281
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-030-34025-4
950 $a Biomedical and Life Sciences (Springer-11642)